159 related articles for article (PubMed ID: 33813428)
21. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials.
Ichinose Y; Kato H; Koike T; Tsuchiya R; Fujisawa T; Shimizu N; Watanabe Y; Mitsudomi T; Yoshimura M;
Lung Cancer; 2001 Oct; 34(1):29-36. PubMed ID: 11557110
[TBL] [Abstract][Full Text] [Related]
22. A prediction model for N2 disease in T1 non-small cell lung cancer.
Zhang Y; Sun Y; Xiang J; Zhang Y; Hu H; Chen H
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1360-4. PubMed ID: 22819364
[TBL] [Abstract][Full Text] [Related]
23. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
24. Extended sleeve lobectomy: one more step toward avoiding pneumonectomy in centrally located lung cancer.
Berthet JP; Paradela M; Jimenez MJ; Molins L; Gómez-Caro A
Ann Thorac Surg; 2013 Dec; 96(6):1988-97. PubMed ID: 24035301
[TBL] [Abstract][Full Text] [Related]
25. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
Matsunaga T; Suzuki K; Takamochi K; Oh S
Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
[TBL] [Abstract][Full Text] [Related]
26. Thoracoscopic segmentectomy with intraoperative evaluation of sentinel nodes for stage I non-small cell lung cancer.
Moroga T; Yamashita S; Tokuishi K; Miyawaki M; Anami K; Yamamoto S; Kawahara K
Ann Thorac Cardiovasc Surg; 2012; 18(2):89-94. PubMed ID: 22082811
[TBL] [Abstract][Full Text] [Related]
27. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
28. Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease.
Razi SS; Nguyen D; Villamizar N
J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2469-2483.e4. PubMed ID: 31928821
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of bulky swollen lymph nodes in cN1 non-small cell lung cancer patients.
Samejima J; Nakao M; Matsuura Y; Uehara H; Mun M; Nakagawa K; Motoi N; Masuda M; Ishikawa Y; Okumura S
Jpn J Clin Oncol; 2015 Nov; 45(11):1050-4. PubMed ID: 26355162
[TBL] [Abstract][Full Text] [Related]
30. Clinical predictors of N2 disease in non-small cell lung cancer.
Takamochi K; Nagai K; Suzuki K; Yoshida J; Ohde Y; Nishiwaki Y
Chest; 2000 Jun; 117(6):1577-82. PubMed ID: 10858386
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Importance of the Lymph Node Factor in Surgically Resected Non-Small Cell Lung Cancer.
Tezel C; Dogruyol T; Alpay L; Akyıl M; Evman S; Metin S; Baysungur V; Yalcinkaya I
Thorac Cardiovasc Surg; 2020 Mar; 68(2):183-189. PubMed ID: 30388719
[TBL] [Abstract][Full Text] [Related]
32. Surgical Outcomes in Patients With Centrally Located Non-small Cell Lung Cancer.
Tsukioka T; Izumi N; Komatsu H; Inoue H; Matsuda Y; Ito R; Kimura T; Nishiyama N
In Vivo; 2021; 35(5):2815-2820. PubMed ID: 34410973
[TBL] [Abstract][Full Text] [Related]
33. Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer.
Thornblade LW; Mulligan MS; Odem-Davis K; Hwang B; Waworuntu RL; Wolff EM; Kessler L; Wood DE; Farjah F
Ann Thorac Surg; 2018 Nov; 106(5):1460-1467. PubMed ID: 30031845
[TBL] [Abstract][Full Text] [Related]
34. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
[TBL] [Abstract][Full Text] [Related]
35. Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study.
Miao H; Shaolei L; Nan L; Yumei L; Shanyuan Z; Fangliang L; Yue Y
Thorac Cancer; 2019 Jun; 10(6):1453-1460. PubMed ID: 31127706
[TBL] [Abstract][Full Text] [Related]
36. [Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].
Liu K; Chen HL; You QS; Huang JF; Wang H
Ai Zheng; 2009 Jul; 28(7):725-9. PubMed ID: 19624899
[TBL] [Abstract][Full Text] [Related]
37. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
[TBL] [Abstract][Full Text] [Related]
38. Thoracoscopic lobectomy with systemic lymph node dissection for lymph node positive non-small cell lung cancer--is thoracoscopic lymph node dissection feasible?
Shiraishi T; Hiratsuka M; Yoshinaga Y; Yamamoto S; Iwasaki A; Shirakusa T
Thorac Cardiovasc Surg; 2008 Apr; 56(3):162-6. PubMed ID: 18365976
[TBL] [Abstract][Full Text] [Related]
39. Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.
Kasprzyk M; Dyszkiewicz W; Piwkowski C; Brudlo M; Galecki B; Gabryel P; Gasiorowski L
Neoplasma; 2013; 60(1):62-7. PubMed ID: 23067218
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
